Enzyme Replacement Therapy for Pompe Disease Market to Reach $350 Million by 2025, Driven by Expanding Clinical Applications The global enzyme replacement therapy (ERT) targeting Pompe disease market ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

Genzyme continued to drive growth for Sanofi in the first quarter, helped along by the company’s vaccines unit, but diabetes drugs are still struggling. Net sales were €8,391 million, an ...